Patients taking rituximab could benefit from third Covid vaccine dose
ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows immunocompromised patients
Source: miragenews.com
Page 2 - Michael Bonelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Bonelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Bonelli Today - Breaking & Trending Today
Third Vaccine Dose May Protect Those With Autoimmune Diseases
As Michael Bonelli, senior author of the Vienna study, explains: “B cells constitute an important cell population for the development of antibodies. We were able to show that more than 50% of patients receiving B-cell-depleting treatment with rituximab still develop antibodies to SARS-CoV-2 [Covid-19], and that there is potentially additional protection via a cellular immune response.” This underscores the importance of vaccinating immunosuppressed patients against Covid, Bonelli said, while his colleague Daniel Aletaha, head of the university’s division of rheumatology, said they also ...
Source: huffingtonpost.co.uk